Nanotechnology News

RSS
NanoViricides Announces Drug Candidate Reduces Herpes Simplex Viral Load by 99.99 Percent

NanoViricides Announces Drug Candidate Reduces Herpes Simplex Viral Load by 99.99 Percent

GC Research Whitepaper Addressing Five Nanotechnology Market

Nanotechnology and Its Impact on the Energy Sector

CMOSIS Raises 3 Million Euros in Additional Capital for Corporate Expansion

CMOSIS Raises 3 Million Euros in Additional Capital for Corporate Expansion

"Molecular Condom" Protecting Women from AIDS in Africa and Other Impoverished Areas

"Molecular Condom" Protecting Women from AIDS in Africa and Other Impoverished Areas

New Technology Improving Cancer Research

New Technology Improving Cancer Research

Next Alternative Introduces Carbon Nanotube Technology with Car Battery

Carbon Nanotubes and Graphene Having Huge Potential in Electrical and Electronic Applications

Carbon Nanotubes and Graphene Having Huge Potential in Electrical and Electronic Applications

Researchers Model the Nano World

Tool Dedicated to Help Decision Makers Evaluate MEMS Companies' Corporate Value and Growth Strategies

Seminar of Aspects of Electron Microscopy and Microanalysis

Seminar of Aspects of Electron Microscopy and Microanalysis

An Insight into How Fibrin Clots Behave from the Centimeter to the Nanometer Scale

An Insight into How Fibrin Clots Behave from the Centimeter to the Nanometer Scale

How Carbon Nanoparticles Would Affect Fruit Flies

How Carbon Nanoparticles Would Affect Fruit Flies

Viscotek to Show Nanomaterials Analysis Equipment at ACS Fall Meeting

Viscotek to Show Nanomaterials Analysis Equipment at ACS Fall Meeting

Zetasizer Nano from Malvern Fast Emerging as System of Choice for Particle Characterization

Zetasizer Nano from Malvern Fast Emerging as System of Choice for Particle Characterization

News Categories

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.